BOK Financial’s Tandem Diabetes Care TNDM Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q4
Sell
-66
Closed -$2.67K 1448
2024
Q3
$2.67K Buy
+66
New +$2.8K ﹤0.01% 1126
2024
Q2
Sell
-23,817
Closed -$806K 1261
2024
Q1
$806K Buy
23,817
+5,345
+29% +$143K 0.01% 506
2023
Q4
$546K Sell
18,472
-3,942
-18% -$81.8K 0.01% 545
2023
Q3
$388K Buy
+22,414
New +$616K 0.01% 570
2023
Q2
Sell
-12,091
Closed -$491K 1176
2023
Q1
$491K Buy
+12,091
New +$501K 0.01% 565

Other funds holding TNDM

BOK Financial's TNDM Position: Q4 2024 in Review

BOK Financial sold out of Tandem Diabetes Care (TNDM) in Q4 2024, closing a stake of 66 shares — an estimated $2.67K sold.

BOK Financial first reported a position in TNDM in Q1 2023 and held it in 5 quarters. The position peaked at $806K in Q1 2024. 316 funds tracked by Wall St. Rank hold TNDM as of Q4 2024.

  • BOK Financial reported no remaining Tandem Diabetes Care position as of Q4 2024 after selling out during the quarter.
  • BOK Financial sold 66 Tandem Diabetes Care shares in Q4 2024, an estimated $2.67K.
  • BOK Financial first reported a position in Tandem Diabetes Care in Q1 2023 and held it in 5 quarters.
  • BOK Financial's Tandem Diabetes Care position peaked at $806K in Q1 2024.
  • 316 funds tracked by Wall St. Rank held Tandem Diabetes Care as of Q4 2024.

Based on BOK Financial's 13F filing for Q4 2024, filed 14 Feb 2025.